scholarly journals CHARACTERIZATION OF SOME PROBIOTIC PROPERTIES OF LACTOBACILLUS GASSERI MA-1 FROM HUMAN MILK

Author(s):  
Meltem AŞAN ÖZÜSAĞLAM ◽  
Ayşe GÜNYAKTI
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Fang Fang ◽  
Jie Xu ◽  
Qiaoyu Li ◽  
Xiaoxuan Xia ◽  
Guocheng Du

2011 ◽  
Vol 10 (4) ◽  
pp. 1746-1754 ◽  
Author(s):  
Yalin Liao ◽  
Rudy Alvarado ◽  
Brett Phinney ◽  
Bo Lönnerdal

2011 ◽  
Vol 27 (2) ◽  
pp. 155-162 ◽  
Author(s):  
Ying-Ying Jin ◽  
Wei Zhao ◽  
Rui-Ming Cao ◽  
Xi Wang ◽  
Sheng-Mei Wu ◽  
...  

1969 ◽  
Vol 130 ◽  
pp. 59-65 ◽  
Author(s):  
R.M. Parry ◽  
R.C. Chandan ◽  
K.M. Shahani

Glycobiology ◽  
2020 ◽  
Vol 30 (10) ◽  
pp. 774-786 ◽  
Author(s):  
Sara Porfirio ◽  
Stephanie Archer-Hartmann ◽  
G Brett Moreau ◽  
Girija Ramakrishnan ◽  
Rashidul Haque ◽  
...  

Abstract Human breast milk is an incredibly rich and complex biofluid composed of proteins, lipids and complex carbohydrates, including a diverse repertoire of free human milk oligosaccharides (HMOs). Strikingly, HMOs are not digested by the infant but function as prebiotics for bacterial strains associated with numerous benefits. Considering the broad variety of beneficial effects of HMOs, and the vast number of factors that affect breast milk composition, the analysis of HMO diversity and complexity is of utmost relevance. Using human milk samples from a cohort of Bangladeshi mothers participating in a study on malnutrition and stunting in children, we have characterized breast milk oligosaccharide composition by means of permethylation followed by liquid chromatography coupled with high-resolution tandem mass spectrometry (LC-MS/MS) analysis. This approach identified over 100 different glycoforms and showed a wide diversity of milk composition, with a predominance of fucosylated and sialylated HMOs over nonmodified HMOs. We observed that these samples contain on average 80 HMOs, with the highest permethylated masses detected being >5000 mass units. Here we report an easily implemented method developed for the separation, characterization and relative quantitation of large arrays of HMOs, including higher molecular weight sialylated HMOs. Our ultimate goal is to create a simple, high-throughput method, which can be used for full characterization of sialylated and/or fucosylated HMOs. These results demonstrate how current analytical techniques can be applied to characterize human milk composition, providing new tools to help the scientific community shed new light on the impact of HMOs during infant development.


2009 ◽  
Vol 59 (3) ◽  
pp. 485-491 ◽  
Author(s):  
Başar Uymaz ◽  
Ömer Şimşek ◽  
Nefise Akkoç ◽  
Haluk Ataoğlu ◽  
Mustafa Akçelik

2006 ◽  
Vol 72 (8) ◽  
pp. 5376-5383 ◽  
Author(s):  
M. Vancanneyt ◽  
G. Huys ◽  
K. Lefebvre ◽  
V. Vankerckhoven ◽  
H. Goossens ◽  
...  

ABSTRACT A set of 118 strains of the species Lactobacillus rhamnosus was collected, including probiotic strains, research strains with potential probiotic properties, food starter cultures, and human isolates. The majority of the strains were collected from companies, hospitals, or culture collections or were obtained after contacting authors who reported clinical case studies in the literature. The present work aimed to reveal the genotypic relationships between strains of these diverse sources. All strains were initially investigated using fluorescent amplified fragment length polymorphism (FAFLP) with three different primer combinations. Numerical analysis of FAFLP data allowed (i) confirmation of the identification of all strains as members of L. rhamnosus and (ii) delineation of seven stable intraspecific FAFLP clusters. Most of these clusters contained both (potentially) probiotic strains and isolates of human origin. For each of the clusters, strains of different sources were selected for pulsed-field gel electrophoresis (PFGE) of macrorestriction fragments obtained with the enzymes NotI and AscI. Analysis of PFGE data indicated that (i) some (potentially) probiotic strains were indistinguishable from other probiotic strains, suggesting that several companies may use duplicate cultures of the same probiotic strain, and (ii) in a number of cases human isolates from sterile body sites were indistinguishable from a particular probiotic strain, suggesting that some of these isolates may be reisolations of commercial strains.


Sign in / Sign up

Export Citation Format

Share Document